Acetop UK Reports 2025 Loss as Trading Volumes Drop to $9.5 Billion
Acetop Financial Limited posted a £35,691 pretax loss in 2025 after revenue declined and trading volumes fell 21% to about $9.5 billion.
简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:ZuluTrade is the Official Global Partner at iFX EXPO ASIA 2022 and will exhibit at Booth #7.

ZuluTrade, part of the Finvasia Group, will be at iFX EXPO Asia 2022 as the Official Global Partner for the event. The company aspires to become the worlds largest social trading community, offering customer-focused investment solutions and an open environment, where investors on a global level can connect to any trading platform and share their knowledge.
ZuluTrade will be at Booth #7, exhibiting the very best of what wealth management has to offer as well as showcasing many features of the long-awaited ZuluTrade 2.0 update.
The iFX EXPO is the leading B2B exhibition of online trading, financial services and fintech. Organised by Ultimate Fintech, the iFX EXPO Asia will take place at the Centara Grand & Bangkok Convention Centre at CentralWorld.
CEO of Finvasia & ZuluTrade, Tajinder Virk said “We are very excited to be in the region to exhibit our services. ZuluTrade is offering access to Financial Markets to beginners. We believe in a transparent pricing model with zero commissions for stock trading.”
“Were delighted to be meeting partners and affiliates to build successful and lucrative business relationships”
ZuluTrade, a FINVASIA Group company, is one of the most innovative Social Wealth Management platforms in the market right now. The company provides a smooth and simplified social trading experience across multiple instruments including Cryptos, Stock CFDs Forex, Commodities and Indices.
ZuluTrade is one of the most transparent broker agnostic social trading platforms and offers the largest database of signals and strategies currently available across the market, catering to both advanced and novice investors, with many supported languages and state-of-the-art mobile apps.

Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.

Acetop Financial Limited posted a £35,691 pretax loss in 2025 after revenue declined and trading volumes fell 21% to about $9.5 billion.

ORCA MARKETS, a Saint Lucia-based forex broker, is reportedly facing many complaints from users as of mid 2026. They frequently complain about the app that refuses to work properly for hours, preventing them from taking the right position to unleash market movement. Complaints have been made about fund losses and deposit failures on the platform. These allegations made it imperative to investigate the broker on different aspects, including the regulatory oversight. We have done so in this ORCA MARKETS review article.

Did your attempt to withdraw funds from the LOYAL PRIMUS platform lead to your account deactivation by the broker? Did the broker prevent you from withdrawing when you made profits? Did the broker cancel your withdrawal application by accusing you of suspicious trading activity? These allegations have grown in numbers on independent broker review tools such as WikiFX. In this LOYAL PRIMUS review article, we have examined all these allegations thoroughly.

Failed to withdraw funds from the Eurotrader platform despite repeated requests? Do you fail to trade due to persistent login issues? Has the customer support service failed to resolve the issue? Did you also face wide spreads that led to a massive profit reduction? All these user allegations have become strong headlines on broker review platforms such as WikiFX. Through this Eurotrader review article, we have shared the user allegations along with a regulatory overview.